Nitrosamine concerns for rifapentine and rifampicin - Update and FAQs
M
For an update on nitrosamine concerns for rifapentine and rifampicin, click on attached FAQ document.
First velpatasvir active pharmaceutical ingredient (API) prequalified
M
Velpatasvir (WHOAPI-353) manufactured by Mylan Laboratories Ltd has been prequalified by the WHO Prequalification Unit - Medicines Team (PQT/MED) under its API prequalification procedure.
First dihydroartemisinin/piperaquine 30mg/240mg dispersible tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First pretomanid prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: